Original Research
Accepted on 17 Aug 2025
Efficacy and safety of dolutegravir plus lamivudine for patients with late presentation of HIV-1 infection: a retrospective real-world cohort study in Southwest China
in Infectious Diseases: Pathogenesis and Therapy